Sign in

CIK 0000109657

  • Non-accelerated filer
  • Smaller reporting company

GT Biopharma, Inc.

Sign in to watch
Ticker
GTBP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
941620407
Phone
+1 800-304-9888
Business address
505 MONTGOMERY STREET, 10TH FLOOR, SAN FRANCISCO, CA, 94111
Former names
GT Biopharma, Inc., OXIS INTERNATIONAL INC
  1. 4 Grant or award Exec. Chair. and Interim CEO acquired 278,058 shares (grant or award)
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Grant or award CFO & Secretary acquired 100,000 shares (grant or award)
  6. 4 Derivatives Options or other derivatives
  7. 3 Insider Initial Statement of Ownership
  8. 3 Insider Initial Statement of Ownership
  9. 4 Grant or award Director acquired 278,058 shares (grant or award)
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 3 Insider Initial Statement of Ownership
  13. 3 Insider Initial Statement of Ownership
  14. 3 Insider Initial Statement of Ownership
  15. 4 Conversion Director acquired 50,102 shares (conversion)
  16. 3 Insider Initial Statement of Ownership
  17. 4 Open-market buy Director bought 5,083 shares at an average $5.17 ($26,299)
  18. 3 Insider Initial Statement of Ownership
  19. 4 Open-market sale Former Officer and Director sold 183,700 shares at an average $0.34 ($62,837)
  20. 4 Open-market sale Former Officer and Director sold 200,000 shares at an average $0.30 ($60,500)

Page 2 of 8 · 160 filings